Morepen Laboratories Ltd
company logo

Morepen Laboratories Ltd

Pharmaceuticals
Small Cap

-

- (0%)


Morepen Laboratories Ltd Performance

-

-

-

-


-

-

-

-

-

Morepen Laboratories Ltd Fundamentals

2,854.37Cr

29.70

3.37

0.03

1.88

-%

16.57

i buttonClick here to know more about Fundamentals

Morepen Laboratories Ltd Financials

Morepen Laboratories Ltd Financialsright-arrow

Morepen Laboratories Ltd Shareholding Pattern

Morepen Laboratories Ltd Delivery and Volume

About Morepen Laboratories Ltd

Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesi

Sushil Suri

1984

MOREPENLAB

NameDesignation
Sushil SuriChairman & Managing Director
Manoj JoshiNon-Exec. & Independent Dir.
Bhupender Raj WadhwaNon-Exec. & Independent Dir.
Sukhcharan singhNon-Exec. & Independent Dir.
Vipul Kumar SrivatavaCompany Sec. & Compli. Officer
Sanjay SuriWhole-time Director
Praveen Kumar DuttNon-Exec. & Independent Dir.
SavitaNon-Exec. & Independent Dir.
News and Events...

Similar Stocks

What's Trending

Morepen Laboratories Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Morepen Laboratories Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Morepen Laboratories Ltd's share price is ₹56.1 as of 2024-07-16.
Morepen Laboratories Ltd's P/E ratio is 29.7 times as of 2024-07-16.
Morepen Laboratories Ltd's most recent financial reports indicate a price-to-book ratio of 3.37, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Morepen Laboratories Ltd's market capitalization is ₹2854.37 Cr as on 2024-07-16.
The current financial records of Morepen Laboratories Ltd show a 6.71% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Morepen Laboratories Ltd's most recent financial filings, the company has a total asset value of ₹740.42, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Morepen Laboratories Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Morepen Laboratories Ltd's 52-week high and low as of 2024-07-16 are ₹56.7 and ₹55.71, respectively.